Unilateral Acute Idiopathic Blind Spot Enlargement...

Unilateral Acute Idiopathic Blind Spot Enlargement following Second Dose of Covid-19 mRNA Vaccine

Abstract

Acute idiopathic blind spot enlargement (AIBSE) is a rare condition which is poorly understood. To our knowledge, this is the first report of acute idiopathic blind spot enlargement following covid-19 vaccination. We believe there is educational value for ophthalmologists to recognize the potential association of ocular inflammation and new mRNA vaccines.

Authors

Shen C; Tennant M

Journal

Ocular Immunology and Inflammation, Vol. 31, No. 6, pp. 1219–1221

Publisher

Taylor & Francis

Publication Date

July 3, 2023

DOI

10.1080/09273948.2022.2090964

ISSN

0927-3948

Associated Experts

Carl Shen

Assistant Clinical Professor (Adjunct), Faculty of Health Sciences

Visit profile

Labels

Unilateral Acute Idiopathic Blind Spot Enlargement following Second Dose of Covid-19 mRNA Vaccine

Abstract

Authors

Journal

Publisher

Publication Date

DOI

ISSN

Associated Experts

Labels

Fields of Research (FoR)

Sustainable Development Goals (SDG)

Medical Subject Headings (MeSH)

Contact the Experts team